LONG ISLAND JEWISH MEDICAL CEN 27005 76Th Ave, New Hyde Park, NY 11040 7184707675 (Phone), 7184700827 (Fax)
Certifications:
Therapeutic Radiology, 1982
Awards:
Healthgrades Honor Roll
Languages:
English Hebrew
Education:
Medical School Albert Einstein College of Medicine of Yeshiva University Graduated: 1976 Medical School Brookdale University Hospital Medical Center Graduated: 1976 Medical School Harvard Joint Ctr Graduated: 1976 Medical School Harvard Medical School Graduated: 1976 Medical School Nih-Harvard Med Sch Graduated: 1976
This invention relates to a method of enhancing wound healing and to a method of enhancing organ transplantation utilizing scatter factor, either alone or in combination with a growth factor.
Itzhak D. Goldberg - Englewood NJ Eliot M. Rosen - Port Washington NY
Assignee:
North Shore - Long Island Jewish Research Institute - Manhasset NY
International Classification:
A61K 3800
US Classification:
514 12, 514 2, 530324, 530350, 530399
Abstract:
This invention relates to a method of enhancing wound healing and to a method of enhancing organ transplantation utilizing scatter factor, either alone or in combination with a growth factor.
Small-Molecule Modulators Of Hepatocyte Growth Factor/Scatter Factor Activities
Sivaram Pillarisetti - Norcross GA Itzhak D. Goldberg - Englewood NJ
Assignee:
North Shore-Long Island Jewish Health System - New Hyde Park NY
International Classification:
A01N 3500
US Classification:
514685, 514277, 514461, 514438
Abstract:
The invention is directed to small organic molecules having the ability to mimic or agonize hepatocyte growth factor/scatter factor (HGF/SF) activity, or inhibit or antagonize HGF/SF activity, the former useful for promoting, for example, vascularization of tissues or organs for promoting wound or tissue healing, or augmenting or restoring blood flow to ischemic tissues such as the heart following myocardial infarction. Inhibition of cellular growth or proliferation is beneficial in the treatment, for example, of inflammatory diseases such as inflammatory joint and skin diseases, and dysproliferative diseases such as cancer.
Compositions And Agents For Modulating Cellular Proliferation And Angiogenesis
The invention is directed to pharmaceutical compositions containing small organic molecules having the ability to mimic or agonize hepatocyte growth factor/scatter factor (HGF/SF) activity, useful for promoting, for example, vascularization of tissues or organs for promoting wound or tissue healing, or augmenting or restoring blood flow to ischemic tissues such as the heart following myocardial infarction.
Small-Molecule Modulators Of Hepatocyte Growth Factor / Scatter Factor Activities
Sivaram Pillarisetti - Norcross GA, US Itzhak D. Goldberg - Englewood NJ, US
Assignee:
North Shore-Long Island Jewish Health System - New Hyde Park NY
International Classification:
A61K031/415
US Classification:
514406
Abstract:
The invention is directed to small organic molecules having the ability to mimic or agonize hepatocyte growth factor/scatter factor (HGF/SF) activity, or inhibit or antagonize HGF/SF activity, the former useful for promoting, for example, vascularization of tissues or organs for promoting wound or tissue healing, or augmenting or restoring blood flow to ischemic tissues such as the heart following myocardial infarction. Inhibition of cellular growth or proliferation is beneficial in the treatment, for example, of inflammatory diseases such as inflammatory joint and skin diseases, and dysproliferative diseases such as cancer.
Small-Molecule Modulators Of Hepatocyte Growth Factor/Scatter Factor Activities
Sivaram Pillarisetti - Norcross GA, US Itzhak Goldberg - Englewood NJ, US
International Classification:
A61K031/415
US Classification:
514406000
Abstract:
The invention is directed to small organic molecules having the ability to mimic or agonize hepatocyte growth factor/scatter factor (HGF/SF) activity, or inhibit or antagonize HGF/SF activity, the former useful for promoting, for example, vascularization of tissues or organs for promoting wound or tissue healing, or augmenting or restoring blood flow to ischemic tissues such as the heart following myocardial infarction. Inhibition of cellular growth or proliferation is beneficial in the treatment, for example, of inflammatory diseases such as inflammatory joint and skin diseases, and dysproliferative diseases such as cancer.
Small Molecule Modulators Of Hepatocyte Growth Factor (Scatter Factor) Activity
The present invention provides compounds and pharmaceutically acceptable compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases in which hepatocyte growth factor/scatter factor (HGF/SF) or the activities thereof, or agonists or antagonists thereof, have a therapeutically useful role.
Enhancement Of Cellular Transplantation Using Small Moleucle Modulators Of Hepatocyte Growth Factor (Scatter Factor) Activity
The present invention provides methods for enhancing cellular transplantation by exposing cells in vitro or ex vivo, or a recipient of cells, to a small molecule hepatocyte growth factor/scatter factor mimetic. Exemplary compounds are described.
Name / Title
Company / Classification
Phones & Addresses
Itzhak Goldberg President
ANGION BIOMEDICA CORP Commercial Physical Research
51 Charles Lindbergh Blvd, Uniondale, NY 11553 1050 Stewart Ave, Garden City, NY 11530 5163261200
Itzhak David Goldberg
Itzhak Goldberg MD Radiology
270-05 76 Ave, Glen Oaks, NY 11004 7184707196
Itzhak Goldberg President
Rxr Realty Real Estate Investment Trust
51 Charles Lindbergh Blvd, Hempstead, NY 11553 5162221513
Isbn (Books And Publications)
Managing The Enterprise In Transition While Coping With Inflation